BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antiviral properties of novel tetracyclic nucleoside inhibitors of hepatitis C NS5B polymerase. 2012

M Emilia Di Francesco, and Salvatore Avolio, and Gabriella Dessole, and Uwe Koch, and Marco Pompei, and Vincenzo Pucci, and Michael Rowley, and Vincenzo Summa
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A., Merck Research Laboratories Rome, Pomezia, Italy. medifrancesco@mdanderson.org

As part of an ongoing medicinal chemistry effort to identify novel nucleoside inhibitors of HCV NS5B polymerase, we report the discovery of a novel series of 2'-C-Methyl-ribose nucleoside derivatives bearing a 7-aryl and 7-heteroaryl- substituted 7-deaza-adenine nucleobase. A reliable platform for the synthesis and simplified purification of the corresponding nucleoside triphosphates (NTPs) was established, enabling a solid understanding of the SAR relationship within the series. By this approach, we identified the novel analogs 13a and 13b that demonstrated micromolar levels of cellular activity, and the NTPs of which, 16a and 16b, are excellent inhibitors of NS5B with IC(50) = 0.1 μM, a level of intrinsic potency similar to that of previous and current clinical candidates.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012324 RNA-Dependent RNA Polymerase An enzyme that catalyses RNA-template-directed extension of the 3'- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. (Enzyme Nomenclature, 1992, p293) Nucleoside-Triphosphate:RNA Nucleotidyltransferase (RNA-directed),RNA Replicase,RNA-Dependent RNA Replicase,RNA-Directed RNA Polymerase,RNA Dependent RNA Polymerase,RNA Dependent RNA Replicase,RNA Directed RNA Polymerase,RNA Polymerase, RNA-Dependent,RNA Polymerase, RNA-Directed,RNA Replicase, RNA-Dependent,Replicase, RNA,Replicase, RNA-Dependent RNA
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D017361 Viral Nonstructural Proteins Proteins encoded by a VIRAL GENOME that are not structural components of VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY. Nonstructural Proteins, Viral,NS Proteins, Viral,Viral NS Proteins,Viral Non-Structural Proteins,Viral Nonstructural Protein,Viral Nonstructural Proteins NS1,Viral Nonstructural Proteins NS2,Nonstructural Protein, Viral,Viral Non Structural Proteins
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

M Emilia Di Francesco, and Salvatore Avolio, and Gabriella Dessole, and Uwe Koch, and Marco Pompei, and Vincenzo Pucci, and Michael Rowley, and Vincenzo Summa
Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase.
February 2009, Bioorganic & medicinal chemistry letters,
M Emilia Di Francesco, and Salvatore Avolio, and Gabriella Dessole, and Uwe Koch, and Marco Pompei, and Vincenzo Pucci, and Michael Rowley, and Vincenzo Summa
Nucleoside Inhibitors of Hepatitis C Virus NS5B Polymerase: A Systematic Review.
January 2016, Current drug targets,
M Emilia Di Francesco, and Salvatore Avolio, and Gabriella Dessole, and Uwe Koch, and Marco Pompei, and Vincenzo Pucci, and Michael Rowley, and Vincenzo Summa
SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase.
February 2006, Journal of medicinal chemistry,
M Emilia Di Francesco, and Salvatore Avolio, and Gabriella Dessole, and Uwe Koch, and Marco Pompei, and Vincenzo Pucci, and Michael Rowley, and Vincenzo Summa
Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase.
March 2012, Journal of medicinal chemistry,
M Emilia Di Francesco, and Salvatore Avolio, and Gabriella Dessole, and Uwe Koch, and Marco Pompei, and Vincenzo Pucci, and Michael Rowley, and Vincenzo Summa
Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: potent allosteric inhibitors of the hepatitis C virus NS5B polymerase.
April 2012, Bioorganic & medicinal chemistry letters,
M Emilia Di Francesco, and Salvatore Avolio, and Gabriella Dessole, and Uwe Koch, and Marco Pompei, and Vincenzo Pucci, and Michael Rowley, and Vincenzo Summa
Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase.
January 2015, Archiv der Pharmazie,
M Emilia Di Francesco, and Salvatore Avolio, and Gabriella Dessole, and Uwe Koch, and Marco Pompei, and Vincenzo Pucci, and Michael Rowley, and Vincenzo Summa
Non-nucleoside inhibitors binding to hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition.
August 2006, Journal of molecular biology,
M Emilia Di Francesco, and Salvatore Avolio, and Gabriella Dessole, and Uwe Koch, and Marco Pompei, and Vincenzo Pucci, and Michael Rowley, and Vincenzo Summa
Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors.
November 2006, Journal of medicinal chemistry,
M Emilia Di Francesco, and Salvatore Avolio, and Gabriella Dessole, and Uwe Koch, and Marco Pompei, and Vincenzo Pucci, and Michael Rowley, and Vincenzo Summa
Antiviral activity and mode of action of TMC647078, a novel nucleoside inhibitor of the hepatitis C virus NS5B polymerase.
August 2011, Antimicrobial agents and chemotherapy,
M Emilia Di Francesco, and Salvatore Avolio, and Gabriella Dessole, and Uwe Koch, and Marco Pompei, and Vincenzo Pucci, and Michael Rowley, and Vincenzo Summa
Design, synthesis, assessment, and molecular docking of novel pyrrolopyrimidine (7-deazapurine) derivatives as non-nucleoside hepatitis C virus NS5B polymerase inhibitors.
May 2016, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!